Biotech startups in Bayern, Germany
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Tubulis | Munich | Series C | $400.6M | 2025-10-15 |
| Orbem | Munich | Series B | $64.6M | 2026-01-20 |
| UniteLabs | Munich | Pre-seed | $3.1M | 2025-04-03 |
| Omegga GmbH | Munich | Seed | $11.7M | 2026-04-24 |
| mbiomics | Munich | Series A | $12.0M | 2026-04-28 |
| smartbax | Munich | Seed | $5.5M | 2026-06-30 |
| Insempra | Planegg | Series A | $20.0M | 2024-05-07 |
| CatalYm | Planegg | Series D | $150.0M | 2024-07-16 |
8 rows of the CSV in 5 of its 18 columns.
- The 61 biotech startups in Bayern, Germany have raised $1.5B in total.
- 14 of them closed their most recent round in the last 12 months, $181.3M combined.
- The largest of those rounds is Orbem's $64.6M Series B, dated January 2026.
- The most recent is smartbax's $5.5M seed round on 30 June 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 14 of them, more than any other fund.
- Health care is the most common other sector, with 44 companies (72%).
- 39% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (48% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 61| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| smartbax | Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. | Biotech | Munich | Seed | $5.5M | 2026-06-30 | $7.5M | HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund | 1 to 10 | 2021 |
| mbiomics | mbiomics is a biotechnology company. | Biotech | Munich | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| Omegga GmbH | Omegga GmbH develops in-ovo sexing technology that identifies male chicks before hatching to prevent their killing. | Artificial intelligence | Munich | Seed | $11.7M | 2026-04-24 | $11.7M | EIC Accelerator, GETTY | 1 to 10 | 2022 |
| Orbem | Orbem provides AI-powered imaging and analytics for non-invasive biological insights. | Artificial intelligence | Munich | Series B | $64.6M | 2026-01-20 | $106.5M | European Innovation Council, Possible Ventures, 83North +1 | 101 to 250 | 2019 |
| Tubulis | Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications. | Biotech | Munich | Series C | $400.6M | 2025-10-15 | $616.9M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, Seventure Partners +1 | 51 to 100 | 2012 |
| UniteLabs | UniteLabs provides an automation operating system for laboratories. | Biotech | Munich | Pre-seed | $3.1M | 2025-04-03 | $3.1M | Venture Kick | 11 to 50 | 2022 |
| CatalYm | CatalYm develops immunotherapies to treat cancer. | Biotech | Planegg | Series D | $150.0M | 2024-07-16 | $260.9M | Bayern Kapital, Forbion Capital Partners, Novartis Venture Fund +1 | 11 to 50 | 2016 |
| iThera Medical | iThera Medical develops proprietary MSOT imaging technology for preclinical and clinical applications. | Biotech | Munich | Series D | $13.8M | 2022-12-21 | $42.3M | European Innovation Council, Bayern Kapital, German Federal Ministry of Research, Technology and Space +1 | 11 to 50 | 2010 |
Table 1. Biotech startups in Bayern, Germany: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 61.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Orbem | Orbem provides AI-powered imaging and analytics for non-invasive biological insights. | Artificial intelligence | Munich | Series B | $64.6M | 2026-01-20 | $106.5M | European Innovation Council, Possible Ventures, 83North +1 | 101 to 250 | 2019 |
| 2 | mbiomics | mbiomics is a biotechnology company. | Biotech | Munich | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| 3 | Omegga GmbH | Omegga GmbH develops in-ovo sexing technology that identifies male chicks before hatching to prevent their killing. | Artificial intelligence | Munich | Seed | $11.7M | 2026-04-24 | $11.7M | EIC Accelerator, GETTY | 1 to 10 | 2022 |
| 4 | smartbax | Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. | Biotech | Munich | Seed | $5.5M | 2026-06-30 | $7.5M | HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund | 1 to 10 | 2021 |
Table 2. Biotech startups in Bayern, Germany: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 14 | 23% | 2 | smartbax, mbiomics |
| 2 | Bayern Kapital | Venture capital firm | Landshut, Germany | 11 | 18% | 1 | mbiomics |
| 3 | European Innovation Council | Startup accelerator | Brussels, Belgium | 3 | 5% | 1 | Orbem |
| 4 | MIG Capital | Venture capital firm | Munich, Germany | 3 | 5% | 1 | mbiomics |
| 5 | KfW | Government investment office | Frankfurt, Germany | 3 | 5% | ||
| 6 | Andera Partners | Private equity firm | Paris, France | 2 | 3% | ||
| 7 | Possible Ventures | Venture capital firm | Munich, Germany | 2 | 3% | 1 | Orbem |
| 8 | Forbion Capital Partners | Private equity firm | Naarden, The Netherlands | 2 | 3% | ||
| 9 | OCCIDENT | Family office | Munich, Germany | 2 | 3% | ||
| 10 | German Federal Ministry of Research, Technology and Space | Government investment office | Bonn, Germany | 2 | 3% | ||
| 11 | Gilde Healthcare | Private equity firm | Utrecht, The Netherlands | 2 | 3% | ||
| 12 | Y Combinator | Startup accelerator | Mountain View, United States | 2 | 3% | ||
| 13 | UVC Partners | Venture capital firm | Garching, Germany | 2 | 3% | ||
| 14 | Life Science Fonds Esslingen | Venture capital firm | Esslingen, Germany | 2 | 3% | ||
| 15 | BioM Venture Capital | Venture capital firm | Martinsried, Germany | 2 | 3% |
Table 3. Biotech startups in Bayern, Germany: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 44 | 72% | $1.3B |
| Software | 8 | 13% | $140.3M |
| Artificial intelligence | 5 | 8% | $137.2M |
| Hardware | 3 | 5% | $118.2M |
| Fintech | 1 | 2% | |
| Cybersecurity | 1 | 2% |
Table 4. Biotech startups in Bayern, Germany by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 6 | 10% | $2.1M |
| Seed | 19 | 31% | $3.1M |
| Series A | 17 | 28% | $19.0M |
| Series B | 12 | 20% | $11.0M |
| Series C | 2 | 3% | $400.6M |
| Series D+ | 5 | 8% | $13.8M |
Table 5. Biotech startups in Bayern, Germany by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Munich | 26 | 43% |
| Martinsried | 8 | 13% |
| Planegg | 6 | 10% |
| Würzburg | 2 | 3% |
| Regensburg | 2 | 3% |
| Garching Bei München | 2 | 3% |
| Eßlingen | 2 | 3% |
| Monheim | 2 | 3% |
| Oberschleißheim | 1 | 2% |
| Utting Am Ammersee | 1 | 2% |
| Langenpreising | 1 | 2% |
| Herzogenaurach | 1 | 2% |
Table 6. Biotech startups in Bayern, Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| June 2026 | 2 | 14% | $55.5M |
| May 2026 | 2 | 14% | $6.5M |
| April 2026 | 4 | 29% | $26.3M |
| March 2026 | 1 | 7% | |
| January 2026 | 3 | 21% | $67.2M |
| December 2025 | 2 | 14% | $25.9M |
Table 7. Biotech startups in Bayern, Germany: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 12 | 20% | $155.4M |
| 2025 | 8 | 13% | $437.4M |
| 2024 | 8 | 13% | $240.8M |
| 2023 | 3 | 5% | $13.7M |
| 2022 | 4 | 7% | $29.1M |
| 2021 | 4 | 7% | $100.8M |
Table 8. Biotech startups in Bayern, Germany by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 8 | 13% |
| 2020 to 2022 | 16 | 26% |
| 2015 to 2019 | 13 | 21% |
| 2010 to 2014 | 11 | 18% |
| Before 2010 | 13 | 21% |
Table 9. Biotech startups in Bayern, Germany by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 29 | 48% |
| 11 to 50 | 26 | 43% |
| 51 to 100 | 3 | 5% |
| 101 to 250 | 2 | 3% |
| 501 to 1,000 | 1 | 2% |
Table 10. Biotech startups in Bayern, Germany by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Bayern, Germany. On 16 November 2026 that is 61 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 61 rows: 18 have no round amount, 0 no city and 18 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Bayern, Germany are on the list?
- 61, in the file dated 16 November 2026. 14 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 61 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.